St. Jude's Departure From AdvaMed Highlights Inherent Industry Tensions

St. Jude Medical CEO Daniel Starks has resigned from AdvaMed's board of directors and the company has left the organization, citing "strong dissent" over how to respond to proposed medical device fees in pending health reform legislation

More from Archive

More from Medtech Insight